Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.

Molecular oncology - 1 Mar 2016

Siravegna Giulia, Bardelli Alberto

Abstract excerpt

Most solid tumors, including colorectal cancers, shed cell-free DNA (ctDNA) in the blood. ctDNA can be analyzed to generate molecular profiles which capture the heterogeneity of the disease more comprehensively then tumor tissue biopsies. This approach commonly called 'liquid biopsy' can be applied to monitor response to therapy, to assess minimal residual disease and to uncover the emergence of drug resistance....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor
Share to Colon

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to DNA, Neoplasm

Share to Drug Resistance, Neoplasm

Share to Genotyping Techniques

Share to Rectum

Source

Open in PubMed Open full text

Identifiers

PMID: 26774880
DOI: 10.1016/j.molonc.2015.12.005
PMCID: PMC5528968

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients.PMID 26774880Read ↗

Circulating tumor DNA in colorectal cancer: biology, methods and applicationsSemantic proximity Read ↗

Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer.Semantic proximity Read ↗

[Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics].Semantic proximity Read ↗

Clinical utility of circulating tumor DNA for colorectal cancerSemantic proximity Read ↗

Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer.Semantic proximity Read ↗

Circulating Tumor DNA: The Dawn of a New Era in the Optimization of Chemotherapeutic Strategies for Metastatic Colo-Rectal Cancer Focusing on RAS MutationSemantic proximity Read ↗

Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From FictionSemantic proximity Read ↗

Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients.Semantic proximity Read ↗

Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applicationsSemantic proximity Read ↗

Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and predictionSemantic proximity Read ↗

Use of Circulating Cell-Free DNA to Guide Precision Medicine in Patients with Colorectal Cancer.Semantic proximity Read ↗

Circulating Tumor DNA as a Liquid Biopsy for CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.